| CONSEJO NACIONAL DE INVESTIGACIONES CIENTIFICAS Y TECNICAS (CONICET) Patent applications |
| Patent application number | Title | Published |
|---|
| 20120022792 | METHOD OF QUANTIZATION OF MAGNETIC NANOPARTICLE ABSORPTION INTO ANIMAL TISSUES, AND EQUIPMENT FOR DOING IT - A method of quantization of magnetic nanoparticle absorption in animal tissues includes determination of the number of magnetic nanoparticles absorbed in animal tissues by magnetization measurements. The method is based on the measurement of magnetization versus magnetic field applied of the tissue sample absorbed with the nanoparticles obtaining their saturation magnetization. This magnitude is compared to the saturation magnetization of the same nanoparticles found in the tissue for the determination of the absolute number of magnetic nanoparticles in the animal tissue studied. The method includes preparing the samples for the sample holder, measuring the magnetization vs. applied magnetic field of a known number of magnetic nanoparticles, determining the saturation magnetization of the sample to be studied by measuring the magnetization and calculating the nanoparticle mass in the tissues from the data measured (saturation magnetization of the sample and of calibration of nanoparticles). | 01-26-2012 |
| 20110046141 | USE OF PDE5 INHIBITORS FOR TREATING CIRCADIAN RHYTHM DISORDERS - A method of altering circadian rhythm in a mammal is provided. In certain embodiments, the method comprising: administering to the mammal a PDE5 inhibitor, e.g., sildenafil, vardenafil, tadalafil or zaprinast. The method may be employed to prevent a circadian rhythm disorders including, but not limited to transmeridian flight disorder (i.e., “jet-lag”), shiftwork-related disorder, seasonal affected disorder and insomnia by phase delay or phase advance. | 02-24-2011 |
| 20110034409 | USE OF PHARMACEUTICAL COMPOUND IN THE TREATMENT OF WOUNDS - A pharmaceutical composition that can be used in the treatment of wounds, comprising at least a sulfated polysaccharide and wherein the polysaccharide/s are in the form of solids as powder, flakes or sheets obtained through a lyophylization process. Particularly, this invention relates to the use of one or more sulfated polysaccharides, as solids in the form of sheets obtained by lyophylization, in the healing of wounds in humans and animals. | 02-10-2011 |
| 20110003796 | METHOD FOR THE TREATMENT OF PSYCHIC DISORDERS - Method for the treatment of psychiatric disorders, comprising administering to a subject in need thereof an amount of fatty acids and a suboptimal dose of at least one antidepressant. Wherein the fatty acid may be omega-3 (ω3), for example the docohexaenoic acid (DHA) and the eicosapentaenoic acid (EPA). The omega-3 fatty acid may be administered orally, in amounts that may be variable, for example in amounts between 0.15 and 1.00 g/kg/day. The antidepressant may be any antidepressant, preferably the antidepressant is fluoxetine or mirtazapine in sub-optimal doses. | 01-06-2011 |
| 20100208242 | METHOD AND APPARATUS FOR DETERMINING THE THERMAL EXPANSION OF A MATERIAL - A focus error signal resulting from the photothermically-induced expansion is measured in a sample of material under analysis. A laser is disposed as a periodically modulated heating source which is directed to the sample and a device for focus error measuring which is directed to de surface being heated. A device measuring focus error generates a signal representative of the displacement of the surface of material in perpendicular direction due to the expansion produced by the periodic heating, which is filtered, either analogically or digitally, to discriminate the displacement component at the frequency in which it was modulated or at any other related frequency, such any harmonic or a sum with any other modulation. The focus error signal, appropriately calibrated, gives a precise and sensitive measure of the magnitude the expansion. Said magnitude and its dependence with the modulation frequency allows the determination of physical properties such as the thermal expansion or thermal diffusivity coefficient, the thickness of a coating film or the absorption coefficient of the light from the heating beam. By varying the wave length of the directed radiation it is possible to determine the absorption spectrum of the sample even for very small sized particles in which the fraction of absorbed energy is very little. | 08-19-2010 |
| 20100120735 | COMPOUND SHOWING ANTI-INFLAMMATORY ACTIVITY AND ANTIVIRAL ACTIVITY, PHARMACEUTICAL COMPOSITIONS COMPRISING THE SAME, A PROCESS FOR OBTAINING THE SAME AND USE OF THE SAME IN THE TREATMENT OF EPIDEMIC KERATOCONJUNCTIVITES AND HERPETIC STROMAL KERATIS - The present invention refers to a compound having anti-inflammatory and antiviral activity according to the following structural formula: | 05-13-2010 |
| 20100065041 | SUNROOF - A sunroof, which is adapted to provide either home passive heating by solar accumulation or passive refrigeration due to its particular structure that additionally provides insulation conditions from the external environment. The sunroof allows incorporating heating and refrigeration during construction of homes for users looking for biosustainable solutions in the long term at present reasonable prices and included in moderately innovative products. The sunroof is comprised by structural sheets (preferable metallic) over which substantially parallel first and second transparent laminar elements are positioned, defining between such sheets and the first laminar elements a first chamber, and forming between first and second laminar elements a second watertight chamber; the first chamber is capable of being filled with water as the external and upper surface of the second transparent laminar element, which is filled with water or opaque and/or reflective liquids. Preferably, a stationary reflective cover is positioned over the laminar elements. | 03-18-2010 |
| 20090004259 | METHODS OF PREPARING A THERAPEUTIC FORMULATION COMPRISING GALECTIN-INDUCED TOLEROGENIC DENDRITIC CELLS - In spite of their pivotal role in orchestrating immunity, dendritic cells (DCs) may be licensed by immunosuppressive signals to become tolerogenic. Here we show that ligation of cell surface glyco-receptors by Galectin-1, an endogenous glycan-binding protein, can drive the differentiation of regulatory DCs with tolerogenic potential in vivo. Galectin-1-differentiated DCs acquired a tolerogenic phenotype characterized by IL-27-dependent, STAT3-mediated and CD45RB | 01-01-2009 |
